Waldencast Reports Q1 2024 Financial Results
May 21, 2024 06:45 ET
|
Waldencast plc.
$68.3 million of Net Revenue+21.0% Comparable Net Revenue: +20.6% Obagi Skincare and +21.5% Milk MakeupAdjusted EBITDA of $11.4 million, up +12.9% vs Q1 2023 WHITE PLAINS, N.Y., May 21, 2024 (GLOBE...
BioNTech to Present Clinical Data Updates for Next-Generation Immunotherapy Candidates at the ASCO Annual Meeting 2024
May 21, 2024 06:45 ET
|
BioNTech SE
MAINZ, Germany, May 21, 2024 – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will present clinical trial data for selected programs from the Company’s diversified immuno-oncology pipeline at...
Dimensional Fund Advisors Ltd. : Form 8.3 - JOHN WOOD GROUP PLC - Ordinary Shares
May 21, 2024 06:44 ET
|
Dimensional Fund Advisors Ltd
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.KEY...
HSBC Bank Plc - Form 8.5 (EPT/RI) - Wood Group (John) plc
May 21, 2024 06:39 ET
|
HSBC Bank Plc
FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITYRule 8.5 of the Takeover Code (the “Code”) ...
BREAKING CEREVEL INVESTIGATION: BFA Law Is Investigating the $45 Per CERE (Nasdaq) Share Offer by AbbVie, Contact the Firm for Details
May 21, 2024 06:38 ET
|
Bleichmar Fonti & Auld
NEW YORK, May 21, 2024 (GLOBE NEWSWIRE) -- Bleichmar Fonti & Auld LLP is investigating the merger between Cerevel Therapeutics Holdings, Inc. (Nasdaq: CERE) and AbbVie, Inc. If you invested in...
Intravenous (IV) Solutions Global Strategic Research Report 2024: Market to Reach $21.7 Billion by 2030, TPN Emerges as the Largest Segment, Growing Demand for Low-Cost Nutrition Solutions
May 21, 2024 06:36 ET
|
Research and Markets
Dublin, May 21, 2024 (GLOBE NEWSWIRE) -- The "Intravenous (IV) Solutions - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Intravenous (IV)...
BREAKING SQUARESPACE INVESTIGATION: BFA Law Is Investigating the $44 Per SQSP (NYSE) Share Buyout by Permira, Contact the Firm for Details
May 21, 2024 06:36 ET
|
Bleichmar Fonti & Auld
NEW YORK, May 21, 2024 (GLOBE NEWSWIRE) -- Bleichmar Fonti & Auld LLP is investigating the Squarespace NYSE: (SQSP) buyout from Permira. If you invested in Squarespace you are encouraged to...
Global Agriculture, Forestry, and Land Use Carbon Credit Industry Research 2024-2033: Increase in Carbon Finance and Investment, & Adoption of Agroforestry and Sustainable Farming Practices
May 21, 2024 06:30 ET
|
Research and Markets
Dublin, May 21, 2024 (GLOBE NEWSWIRE) -- The "Carbon Credit Market for Agriculture, Forestry, and Land Use - A Global and Regional Analysis: Analysis and Forecast, 2023-2033" report has been added...
Planet 13 Highlights the Growth of Planet 13 Florida (VidaCann) Through Q1 Preliminary Financials
May 21, 2024 06:30 ET
|
Planet 13 Holdings Inc.
LAS VEGAS, May 21, 2024 (GLOBE NEWSWIRE) -- Planet 13 Holdings Inc. (CSE: PLTH) (OTCQX: PLNH) (“Planet 13” or the “Company”), a leading vertically-integrated multi-state cannabis company, today...
BiomX Reports First Quarter 2024 Financial Results and Provides Business and Program Updates
May 21, 2024 06:30 ET
|
BiomX
Following merger with Adaptive Phage Therapeutics in March, combined company reports funding sufficient to support important data readouts for lead clinical programs in 2025 Company will host a...
- May 21, 2024 06:36 ET Intravenous (IV) Solutions Global Strategic Research Report 2024: Market to Reach $21.7 Billion by 2030, TPN Emerges as the Largest Segment, Growing Demand for Low-Cost Nutrition Solutions
- May 21, 2024 06:30 ET Global Agriculture, Forestry, and Land Use Carbon Credit Industry Research 2024-2033: Increase in Carbon Finance and Investment, & Adoption of Agroforestry and Sustainable Farming Practices